ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VTXPY Victrex PLC (PK)

0.00
0.00 (0.00%)
25 Jun 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Victrex PLC (PK) USOTC:VTXPY OTCMarkets Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 0.0015 43.60 0.00 14:30:26

Victrex Says 3Q Revenue Grew, But Sees Headwinds for Fiscal Year 2022

09/07/2021 8:12am

Dow Jones News


Victrex (PK) (USOTC:VTXPY)
Historical Stock Chart


From Jun 2021 to Jun 2024

Click Here for more Victrex (PK) Charts.

By Adria Calatayud

 

Victrex PLC said Friday that third-quarter revenue grew and that its order book for the current quarter is robust, helped by restocking, but warned that currency and material inflation headwinds could weigh on its prospects for next year.

The U.K. supplier of polymers said it is set to face a growing impact from foreign-currency headwinds, increasing raw-material inflation, innovation spend and costs associated with commissioning a China manufacturing site for fiscal 2022, although many of its end markets continue to show progress.

For the quarter ended June 30, Victrex said revenue rose to 80.7 million pounds ($111.3 million) from GBP58.8 million for the same period last year. Sales volumes for the quarter were 1,202 metric tons, 49% ahead of the prior year.

The company said it is mindful that its recent performance reflects some benefits from restocking, which means that run rates at the end of fiscal 2021 might be slightly lower than in the third quarter.

Victrex said its sales mix remains skewed toward its industrial end markets, but that its medical segment is recovering as elective surgeries return both in Asia and the U.S. The aerospace end market remains subdued, the company said.

 

Write to Adria Calatayud at adria.calatayud@dowjones.com

 

(END) Dow Jones Newswires

July 09, 2021 03:00 ET (07:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Victrex (PK) Chart

1 Year Victrex (PK) Chart

1 Month Victrex (PK) Chart

1 Month Victrex (PK) Chart